Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 2 960.05 INR 0.49% Market Closed
Market Cap: 369.7B INR
Have any thoughts about
Ajanta Pharma Ltd?
Write Note

Wall Street
Price Targets

AJANTPHARM Price Targets Summary
Ajanta Pharma Ltd

Wall Street analysts forecast AJANTPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AJANTPHARM is 3 019.71 INR with a low forecast of 2 000.81 INR and a high forecast of 3 848.25 INR.

Lowest
Price Target
2 000.81 INR
32% Downside
Average
Price Target
3 019.71 INR
2% Upside
Highest
Price Target
3 848.25 INR
30% Upside
Ajanta Pharma Ltd Competitors:
Price Targets
REC
Recordati Industria Chimica e Farmaceutica SpA
7% Upside
CRON
Cronos Group Inc
25% Upside
SANOFI
Sanofi India Ltd
37% Upside
GLS
Glenmark Life Sciences Ltd
5% Upside
ACB
Aurora Cannabis Inc
56% Upside
NATCOPHARM
Natco Pharma Ltd
5% Downside
CIPLA
Cipla Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
Ajanta Pharma Ltd

For the last 8 years the compound annual growth rate for Ajanta Pharma Ltd's revenue is 12%. The projected CAGR for the next 3 years is 12%.

12%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ajanta Pharma Ltd

For the last 8 years the compound annual growth rate for Ajanta Pharma Ltd's operating income is 8%. The projected CAGR for the next 3 years is 15%.

8%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Ajanta Pharma Ltd

For the last 8 years the compound annual growth rate for Ajanta Pharma Ltd's net income is 9%. The projected CAGR for the next 3 years is 16%.

9%
Past Growth
16%
Estimated Growth
Estimates Accuracy
1%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AJANTPHARM's stock price target?
Price Target
3 019.71 INR

According to Wall Street analysts, the average 1-year price target for AJANTPHARM is 3 019.71 INR with a low forecast of 2 000.81 INR and a high forecast of 3 848.25 INR.

What is Ajanta Pharma Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Ajanta Pharma Ltd's revenue is 12%. The projected CAGR for the next 3 years is 12%.

What is Ajanta Pharma Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Ajanta Pharma Ltd's operating income is 8%. The projected CAGR for the next 3 years is 15%.

What is Ajanta Pharma Ltd's Net Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Ajanta Pharma Ltd's net income is 9%. The projected CAGR for the next 3 years is 16%.

Back to Top